Skip to main content
DCOY logo

DCOY · Decoy Therapeutics Inc. · Short Interest

Track DCOY — free
$1.07 -0.07 (-5.73%)
Market Cap
$743,635
Shares
655,185
Volume · Oct 21 75.59K Avg daily vol (3M) 2.14M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

DCOY Latest Reported Short Interest

FINRA reported 150,336 DCOY shares sold short as of the September 30, 2026 settlement date, an increase of 139,758 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

DCOY Short Interest Forecast

Equibles' model estimates 36,164 shares sold short for the October 15, 2026 settlement, -75.9% versus the latest reported position, with a likely range of 10,763 to 71,057 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 High confidence 97% chance it falls
36,164 -75.9% vs reported
Likely range 10,763 to 71,057 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
67/100
Short interest 22.9% of shares — P99 Days to cover 1.0 — P14 Price vs VWAP -66.8% — P1 Short-volume trend +31.2% — P98 Short interest change +1,321.2% — P99 Worst FTD 116.67% of shares — P100

Positioning score 67.1 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-21 22:02 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 150,336 10,578 +139,758 1.00
2026-09-15 10,578 13,152 -2,574 1.00
2026-08-31 13,152 10,675 +2,477 1.00
2026-08-14 10,675 25,246 -14,571 1.00
2026-07-31 25,246 23,986 +1,260 1.00
2026-07-15 23,986 156,313 -132,327 1.00
2026-06-30 156,313 1,966 +154,347 1.00
2026-06-15 1,966 9,158 -7,192 1.00
2026-05-29 9,158 8,514 +644 1.00
2026-05-15 8,514 11,279 -2,765 1.03
2026-04-30 11,279 23,252 -11,973 1.00
2026-04-15 23,252 19,296 +3,956 1.00
2026-03-31 19,296 28,912 -9,616 1.00
2026-03-13 28,912 25,551 +3,361 1.00
2026-02-27 25,551 33,614 -8,063 3.79
2026-02-13 33,614 37,656 -4,042 1.56
2026-01-30 37,656 89,333 -51,677 1.17
2026-01-15 89,333 18,607 +70,726 1.00

Full FINRA short interest reporting calendar

Showing 1–18 of 18 settlements
Key facts CIK 1615219 CUSIP 79400X602 Visit website Investor relations